Jacob D. Bitran
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in ⓘ
- Oncology 75
- Lung Cancer Research Studies 27
- Peptidase Inhibition and Analysis 11
-
- Lymphoma Diagnosis and Treatment 24
- Co-authors
- Harvey M. Golomb (30 shared papers)Carlos Bekerman (10 shared papers)Brian L. Samuels (4 shared papers)Richard K. Desser (17 shared papers)Stephanie Williams (8 shared papers)S F Williams (3 shared papers)John E. Ultmann (8 shared papers)Paul B. Hoffer (3 shared papers)
- Journals
- Cancer (23 papers)Journal of Clinical Oncology (17 papers)JAMA (8 papers)Blood (5 papers)Seminars in Nuclear Medicine (4 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Jacob D. Bitran
129 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 112
- Oncology 1.5k
- Hematology 378
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 578
- Cancer Research 328
Countries citing papers authored by Jacob D. Bitran
This map shows the geographic impact of Jacob D. Bitran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob D. Bitran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob D. Bitran more than expected).
Fields of papers citing papers by Jacob D. Bitran
This network shows the impact of papers produced by Jacob D. Bitran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob D. Bitran. The network helps show where Jacob D. Bitran may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob D. Bitran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 181 | |
| 2 | 1995 | 150 | |
| 3 | Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. | 1983 | 116 |
| 4 | 1992 | 109 | |
| 5 | 1984 | 93 | |
| 6 | 1989 | 88 | |
| 7 | 1981 | 79 | |
| 8 | 1977 | 77 | |
| 9 | Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. | 1990 | 74 |
| 10 | 1985 | 61 | |
| 11 | 1976 | 57 | |
| 12 | 1981 | 52 | |
| 13 | 1982 | 52 | |
| 14 | 1979 | 50 | |
| 15 | 2007 | 47 | |
| 16 | 1987 | 47 | |
| 17 | 1987 | 45 | |
| 18 | Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy. | 1996 | 43 |
| 19 | 2022 | 43 | |
| 20 | 1977 | 43 |
About Jacob D. Bitran
Jacob D. Bitran is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Pulmonary and Respiratory Medicine and Hematology, having authored 138 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (27 papers), Lung Cancer Treatments and Mutations (26 papers), Lymphoma Diagnosis and Treatment (24 papers), Lung Cancer Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (13 papers), Breast Cancer Treatment Studies (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and Peptidase Inhibition and Analysis (11 papers). The work is most often cited by research in Oncology (1.5k citations), Hematology (378 citations), Pulmonary and Respiratory Medicine (1.1k citations), Pathology and Forensic Medicine (578 citations) and Cancer Research (328 citations). Jacob D. Bitran has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Harvey M. Golomb, Carlos Bekerman, Brian L. Samuels, Richard K. Desser, Stephanie Williams, S F Williams, John E. Ultmann, Paul B. Hoffer, Rosemarie Mick and Philip C. Hoffman. Their work appears in journals such as Cancer, Journal of Clinical Oncology, JAMA, Blood and Seminars in Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.